Cargando…

Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma

Immune checkpoint inhibitors (ICI) have been applied in treating advanced hepatocellular carcinoma (aHCC) patients, but few patients exhibit stable and lasting responses. Moreover, identifying aHCC patients suitable for ICI treatment is still challenged. This study aimed to evaluate whether dissecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jan-Mou, Hung, Yi-Ping, Chou, Kai-Yuan, Lee, Cheng-Yun, Lin, Shian-Ren, Tsai, Ya-Han, Lai, Wan-Yu, Shao, Yu-Yun, Hsu, Chiun, Hsu, Chih-Hung, Chao, Yee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679144/ https://www.ncbi.nlm.nih.gov/pubmed/36425096 http://dx.doi.org/10.3389/fmed.2022.1008855

Ejemplares similares

Precision immunoprofiling by image analysis and artificial intelligence
por: Koelzer, Viktor H., et al.
Publicado: (2018)

Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response
por: Lee, Jan-Mou, et al.
Publicado: (2022)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Low-dose nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial
por: Chao, Heng-Sheng, et al.
Publicado: (2023)

Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
por: Yang, Shih-Hung, et al.
Publicado: (2022)

Prediction for blood lactate during exercise using an artificial intelligence—Enabled electrocardiogram: a feasibility study
por: Huang, Shu-Chun, et al.
Publicado: (2023)

Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study
por: Hsu, Chiun, et al.
Publicado: (2023)

Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Tianbing, et al.
Publicado: (2021)

Building a model for predicting metabolic syndrome using artificial intelligence based on an investigation of whole-genome sequencing
por: Hsu, Nai-Wei, et al.
Publicado: (2022)

Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma: Case report
por: Chen, Yu-Hsiu, et al.
Publicado: (2017)

Characterization of anticoagulant heparinoids by immunoprofiling
por: Wijnhoven, Tessa J., et al.
Publicado: (2007)

An Artificial Intelligence Approach to Bloodstream Infections Prediction
por: Pai, Kai-Chih, et al.
Publicado: (2021)

Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes
por: Kim, Moonsik, et al.
Publicado: (2020)

Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
por: Wu, Wen-Chi, et al.
Publicado: (2022)

Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
por: Lin, Zhong-Zhe, et al.
Publicado: (2013)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
por: Kuo, Hsin-Yu, et al.
Publicado: (2022)

Semi-automated identification of biological control agent using artificial intelligence
por: Liao, Jhih-Rong, et al.
Publicado: (2020)

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
por: Liu, I-Ting, et al.
Publicado: (2021)

Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers
por: Kim, Ji Eun, et al.
Publicado: (2023)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Artificial Intelligence-Assisted Identification of Genetic Factors Predisposing High-Risk Individuals to Asymptomatic Heart Failure
por: Yang, Ning-I, et al.
Publicado: (2021)

Vowel production of Mandarin-speaking hearing aid users with different types of hearing loss
por: Hung, Yu-Chen, et al.
Publicado: (2017)

Artificial intelligence-based education assists medical students’ interpretation of hip fracture
por: Cheng, Chi-Tung, et al.
Publicado: (2020)

Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
por: Yen, Tsai-Hung, et al.
Publicado: (2020)

Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk prediction
por: Huang, Yu-Chang, et al.
Publicado: (2023)

Artificial Intelligence of Object Detection in Skeletal Scintigraphy for Automatic Detection and Annotation of Bone Metastases
por: Liao, Chiung-Wei, et al.
Publicado: (2023)

Immunoprofiles of colorectal cancer from Lynch syndrome
por: Walkowska, Joanna, et al.
Publicado: (2018)

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
por: Busse, Antonia, et al.
Publicado: (2020)

Immunoprofiling of Nonarteritic Anterior Ischemic Optic Neuropathy
por: Mesentier-Louro, Louise A., et al.
Publicado: (2021)

Immunoprofiling of T cell responses in melanoma patients undergoing CPI therapy
por: Talarico, Lee Ann, et al.
Publicado: (2015)

Artificial Intelligence-Enabled Electrocardiography Detects Hypoalbuminemia and Identifies the Mechanism of Hepatorenal and Cardiovascular Events
por: Lee, Yung-Tsai, et al.
Publicado: (2022)

Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
por: Shao, Yu-Yun, et al.
Publicado: (2017)

Point-of-care artificial intelligence-enabled ECG for dyskalemia: a retrospective cohort analysis for accuracy and outcome prediction
por: Lin, Chin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_96g9kfu28al1pm7pp27tbgejdd